Effect of pantoprazole on insulin secretion in drug-naïve patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 108, Issue 1, 2015, Pages e11-e13

  González Ortiz, Manuel ^a,b   Martínez Abundis, Esperanza ^a   Mercado Sesma, Arieh R ^b   Álvarez Carrillo, Rebeca ^b  

^a Human Genetics Program   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Insulin secretion; NCT01541735, clinicaltrials.gov; Proton pump inhibitors; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; PANTOPRAZOLE; PLACEBO; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; GLUCOSE BLOOD LEVEL; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; BLOOD; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; METABOLISM; MIDDLE AGED; SECRETION (PROCESS);

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS;

EID: 84926195311     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.01.039     Document Type: Article

References (18)

1. Suarez-Pinzon W.L., Cembrowski G.S., Rabinovich A. Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton inhibitor restores normoglycaemia in non-obese diabetic mice. Diabetologia 2009, 52:1680-1682.
2. Bödvarsdóttir T.B., Hove K.D., Gotfredsen C.F., Pridal L., Vaag A., Karlsen A.E., et al. Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes. Diabetologia 2010, 53:2220-2223.
3. Mefford I.N., Wade E.U. Proton pump inhibitors as a treatment method for type II diabetes. Med Hypothesis 2009, 73:29-32.
4. Hove K.D., Foerch K., Bödvarsdóttir T.B., Karlsen A.E., Petersen J.S., Vaag A. Treatment with a proton pumps inhibitors improves HbA1c in type 2 diabetes-a retrospective analysis. Diabetes Res Clin Pract 2010, 90:e72-e74.
5. Boj-Carceller D., Bocos-Terraz P., Moreno-Vernis M., Sanz-Paris A., Trincado-Aznar P., Albero-Gamboa R. Are proton pump inhibitors a new antidiabetic drug?. A cross sectional study. World J Diabetes 2011, 2:217-220.
6. Crouch M.A., Mefford I.N., Wade E.U. Proton pump inhibitor therapy associated with lower glycosylated hemoglobin levels in type 2 diabetes. J Am Bord Fam Med 2012, 25:50-54.
7. Singh P.K., Hota D., Dutta O., Sachdeva N., Chakrabarti A., Srinivasan A., et al. Pantoprazole improves glycaemic control in type 2 diabetes. A randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2012, 97:E1-E4.
8. Hove K.D., Brons C., Faerch K., Lund S.S., Petersen J.S., Karlsen A.E., et al. Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study. Diabetologia 2013, 56:22-30.
9. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237(3):E214-E223.
10. Jeyasselan L., Rao P.S.S. Methods of determining samples size in clinical trials. Indian Pediatr 1989, 26:115-121.
11. Rehfeld J.R. Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides. Acta Physiol (Oxf) 2011, 201:405-411.
12. Rehfeld J.R., Stadil F. The effect of gastrin on basal and glucose-stimulated insulin secretion in man. J Clin Invest 1973, 52:1415-1428.
13. Rozengurt E., Walsh J.H. Gastrin, CCK, signalling, and cancer. Annu Rev Physiol 2001, 63:49-76.
14. Lavine J.A., Attie A.D. Gastrointestinal hormones and the regulation of β-cell mass. Ann NY Acad Sci 2010, 1211:41-58.
15. Dockray G.J., Varro A., Dimaline R., Wang T. The gastrins: their production and biological activities. Annu Rev Physiol 2001, 63:119-139.
16. Bouwens L., Rooman I. Regulation of pancreatic beta-cell mass. Physiol Rev 2005, 85:1255-1270.
17. Bonner-Weir S., Weir G.C. New sources of pancreatic β-cells. Nat Biotechnol 2005, 23:857-861.
18. Homa K., Majkowska L. Difficulties in interpreting HbA1c results. Pol Arch Med Wewn 2010, 120:148-154.